you need to also add other stated milestones of commercialisation in Europe (off the already achieved CE Mark approval) and the step into the USA market with the Submission for FDA approval, in Q1 2018
Given the willingness of DSA to be involved and endorse the Epat app here in Aust, my thinking is any discussions with European parties is going to prove successful too.
Ann: Core strategic agreement with Dementia Support Australia, page-107
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $47.43M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.8¢ | $19.97K | 697.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1419145 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 206943 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PCK (ASX) Chart |